Alnajashi, H. Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment. J. Contemp. Med. Sci. 2025, 11.